With the expanded legalization of marijuana, its medical and recreational use have sharply
increased over the past decade. A wide array of new forms of cannabis is available on the …

Nowadays cardiovascular diseases (CVDs) are the major causes for the reduction of the
quality of life. The endocannabinoid system is an attractive therapeutic target for the …

Background Cannabis use and cannabis use disorders are increasing in prevalence,
including among pregnant women. The objective was to evaluate the association of a …

Cannabis ranks among the most commonly used psychotropic drugs worldwide. In the
context of the global movement toward more widespread legalisation, there is a growing …

The endocannabinoid system (ECS) dynamically regulates many aspects of mammalian
physiology. ECS has gained substantial interest since growing evidence suggests that it …

Our study aimed to examine the endothelium (vascular)-protecting effects of chronic
cannabidiol (CBD) administration (10 mg/kg once daily for 2 weeks) in aortas and small …

Aim To measure the association between cannabis use disorder (CUD) and adverse
cardiovascular disease (CVD) outcomes. Design and Setting We conducted a matched …

In endotoxemic models, the inflammatory parameters are altered to a favorable direction as
a response to activation of cannabinoid receptors 1 and 2. The phytocannabinoid Δ9 …

Currently, no treatment can completely cure pulmonary hypertension (PH), which can lead to
right ventricular failure and, consequently, death. Therefore, searching for new therapies …

Systemic and pulmonary hypertension are multifactorial, high-pressure diseases. The first
one is a civilizational condition, and the second one is characterized by a very high mortality …